Ge Healthcare [GEHC] vs Doximity [DOCS] Detailed Stock Comparison

Ge Healthcare

Doximity
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Ge Healthcare wins in 12 metrics, Doximity wins in 7 metrics, with 0 ties. Ge Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Ge Healthcare | Doximity | Better |
---|---|---|---|
P/E Ratio (TTM) | 14.86 | 63.66 | Ge Healthcare |
Price-to-Book Ratio | 3.44 | 13.73 | Ge Healthcare |
Debt-to-Equity Ratio | 107.67 | 1.16 | Doximity |
PEG Ratio | 1.16 | 2.33 | Ge Healthcare |
EV/EBITDA | 11.05 | 54.29 | Ge Healthcare |
Profit Margin (TTM) | 11.22% | 39.88% | Doximity |
Operating Margin (TTM) | 14.62% | 37.48% | Doximity |
EBITDA Margin (TTM) | 14.62% | 37.48% | Doximity |
Return on Equity | 25.80% | 24.25% | Ge Healthcare |
Return on Assets (TTM) | 5.77% | 13.13% | Doximity |
Free Cash Flow (TTM) | $1.55B | $266.74M | Ge Healthcare |
Dividend Yield | 0.27% | N/A | N/A |
1-Year Return | -15.97% | 66.89% | Doximity |
Price-to-Sales Ratio (TTM) | 1.67 | 23.63 | Ge Healthcare |
Enterprise Value | $40.59B | $13.24B | Ge Healthcare |
EV/Revenue Ratio | 2.03 | 22.46 | Ge Healthcare |
Gross Profit Margin (TTM) | 39.65% | 89.18% | Doximity |
Revenue per Share (TTM) | $44 | $3 | Ge Healthcare |
Earnings per Share (Diluted) | $4.92 | $1.18 | Ge Healthcare |
Beta (Stock Volatility) | 1.28 | 1.37 | Ge Healthcare |
Ge Healthcare vs Doximity Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Ge Healthcare | 1.73% | 7.44% | 7.29% | 0.92% | -3.20% | -1.99% |
Doximity | 1.91% | -3.21% | 7.45% | 21.38% | 24.23% | 34.41% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Ge Healthcare | -15.97% | 35.39% | 35.39% | 35.39% | 35.39% | 35.39% |
Doximity | 66.89% | 146.55% | 30.67% | 30.67% | 30.67% | 30.67% |
News Based Sentiment: Ge Healthcare vs Doximity
Ge Healthcare
News based Sentiment: MIXED
October presented a mixed picture for GE HealthCare, with analyst downgrades balanced by upgrades and continued investment in innovation and partnerships. The upcoming Q3 earnings release on October 29th is a key event that will shape the investment narrative and provide clarity on the company's performance.
Doximity
News based Sentiment: MIXED
October brought a mix of positive financial projections and concerning signals for Doximity. While the company is expected to continue growing revenue and earnings, a downgrade from Goldman Sachs, significant insider selling, and potential regulatory risks create uncertainty. This combination of factors makes October a significant month for investors to reassess their positions.
Performance & Financial Health Analysis: Ge Healthcare vs Doximity
Metric | GEHC | DOCS |
---|---|---|
Market Information | ||
Market Cap | $33.37B | $14.07B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 3,567,540 | 1,577,510 |
90 Day Avg. Volume | 3,275,250 | 1,326,787 |
Last Close | $76.82 | $71.99 |
52 Week Range | $57.65 - $94.80 | $40.87 - $85.21 |
% from 52W High | -18.97% | -15.51% |
All-Time High | $94.80 (Feb 10, 2025) | $107.79 (Sep 06, 2021) |
% from All-Time High | -18.97% | -33.21% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.04% | 0.15% |
Quarterly Earnings Growth | 0.14% | 0.29% |
Financial Health | ||
Profit Margin (TTM) | 0.11% | 0.40% |
Operating Margin (TTM) | 0.15% | 0.37% |
Return on Equity (TTM) | 0.26% | 0.24% |
Debt to Equity (MRQ) | 107.67 | 1.16 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $21.27 | $5.47 |
Cash per Share (MRQ) | $8.19 | $4.49 |
Operating Cash Flow (TTM) | $2.00B | $294.12M |
Levered Free Cash Flow (TTM) | $1.58B | $231.29M |
Dividends | ||
Last 12-Month Dividend Yield | 0.27% | N/A |
Last 12-Month Dividend | $0.19 | N/A |
Valuation & Enterprise Metrics Analysis: Ge Healthcare vs Doximity
Metric | GEHC | DOCS |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 14.86 | 63.66 |
Forward P/E | 15.65 | 63.13 |
PEG Ratio | 1.16 | 2.33 |
Price to Sales (TTM) | 1.67 | 23.63 |
Price to Book (MRQ) | 3.44 | 13.73 |
Market Capitalization | ||
Market Capitalization | $33.37B | $14.07B |
Enterprise Value | $40.59B | $13.24B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 2.03 | 22.46 |
Enterprise to EBITDA | 11.05 | 54.29 |
Risk & Other Metrics | ||
Beta | 1.28 | 1.37 |
Book Value per Share (MRQ) | $21.27 | $5.47 |
Financial Statements Comparison: Ge Healthcare vs Doximity
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | GEHC | DOCS |
---|---|---|
Revenue/Sales | $4.78B | $145.91M |
Cost of Goods Sold | $2.77B | $15.79M |
Gross Profit | $2.01B | $130.12M |
Research & Development | $344.00M | $26.80M |
Operating Income (EBIT) | $628.00M | $54.52M |
EBITDA | $842.00M | $57.31M |
Pre-Tax Income | $692.00M | $64.15M |
Income Tax | $104.00M | $10.83M |
Net Income (Profit) | $588.00M | $53.32M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | GEHC | DOCS |
---|---|---|
Cash & Equivalents | $2.45B | $209.61M |
Total Current Assets | $9.74B | $1.09B |
Total Current Liabilities | $9.97B | $156.26M |
Long-Term Debt | $7.06B | $10.19M |
Total Shareholders Equity | $9.42B | $1.08B |
Retained Earnings | $3.81B | $186.89M |
Property, Plant & Equipment | $369.00M | $8.89M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | GEHC | DOCS |
---|---|---|
Operating Cash Flow | $509.00M | $119.90M |
Capital Expenditures | $-152.00M | $0 |
Free Cash Flow | $98.00M | $96.98M |
Debt Repayment | $-257.00M | N/A |
Common Stock Repurchase | N/A | $-26.79M |
Short Interest & Institutional Ownership Analysis
Metric | GEHC | DOCS |
---|---|---|
Shares Short | 7.46M | 4.82M |
Short Ratio | 2.39 | 3.93 |
Short % of Float | 0.02% | 0.04% |
Average Daily Volume (10 Day) | 3,567,540 | 1,577,510 |
Average Daily Volume (90 Day) | 3,275,250 | 1,326,787 |
Shares Outstanding | 456.96M | 188.88M |
Float Shares | 455.23M | 133.22M |
% Held by Insiders | 0.00% | 0.02% |
% Held by Institutions | 0.88% | 0.91% |
Dividend Analysis & Yield Comparison: Ge Healthcare vs Doximity
Metric | GEHC | DOCS |
---|---|---|
Last 12-Month Dividend | $0.19 | N/A |
Last 12-Month Dividend Yield | 0.27% | N/A |
3-Year Avg Annual Dividend | $0.12 | N/A |
3-Year Avg Dividend Yield | 0.04% | N/A |
3-Year Total Dividends | $0.37 | N/A |
Ex-Dividend Date | Oct 24, 2025 | N/A |